## Abstract Uveal melanoma is associated with a high mortality rate once metastases occur, with over >90% of metastatic patients dying within less than 1 year from metastases to the liver. The intraarterial hepatic (iah) administration of the alkylating agent fotemustine holds some promise with res
Infrequent expression of the MAGE gene family in uveal melanomas
✍ Scribed by Kevin A. Mulcahy; Donata Rimoldi; Francis Brasseur; Sheila Rodgers; Danielle Liénard; Marie Marchand; Ian G. Rennie; Anna K. Murray; Catherine A. McIntyre; Kathryn E. Platts; Serge Leyvraz; Thierry Boon; Robert C. Rees
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- French
- Weight
- 659 KB
- Volume
- 66
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## BACKGROUND. The 12 members of the MAGE gene family encode tumor specific antigens that are recognized by autologous cytotoxic T lymphocytes (CTL). The MAGE genes are expressed not only in melanoma but in the other malignant tumors as well. There is, however, little information on their expressi
MACE-I has been identified as a human gene, which directs the expression of an antigen being recognized on melanoma cells by autologous cytolytic T cells. MACE-I is expressed in melanomas and some other tumors. It has been proposed that this gene may be linked to the transformation event and therefo
ized in a human melanoma cell line (MZ2-MEL). 4 Expression The MAGE-1 gene, originally isolated from a human of the MAGE-1 gene on HLA-A1 positive tumor cells directs melanoma cell line, directs the expression of a potential the expression of a nonapeptide that allows specific recognitumor-rejection